Osteoprotegerin Expressed by Osteoclasts

Journal of Dental Research - United States
doi 10.1177/0022034514552677
Full Text
Abstract

Available in full text

Categories
Dentistry
Date
Authors
Publisher

SAGE Publications

Related search

The Ligand for Osteoprotegerin (OPGL) Directly Activates Mature Osteoclasts

Journal of Cell Biology
MedicineCell Biology
1999English

Osteoprotegerin Reverses Osteoporosis by Inhibiting Endosteal Osteoclasts and Prevents Vascular Calcification by Blocking a Process Resembling Osteoclastogenesis

Journal of Experimental Medicine
MedicineAllergyImmunology
2000English

Osteoprotegerin mRNA Is Expressed in Primary Human Osteoblast-Like Cells: Down-Regulation by Glucocorticoids

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
1998English

Transactivation of Human Osteoprotegerin Promoter by GATA-3

Scientific Reports
Multidisciplinary
2015English

Osteoprotegerin Secretion by Mevastatin via P38MAPK and NF-kB

Open Journal of Rheumatology and Autoimmune Diseases
2012English

Regulation of Cytochromecoxidase Activity by C-SRC in Osteoclasts

Journal of Cell Biology
MedicineCell Biology
2003English

Osteoprotegerin Ligand and Osteoprotegerin: Novel Implications for Osteoclast Biology and Bone Metabolism

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
1999English

Dimerization Interface of Osteoprotegerin Revealed by Hydrogen-Deuterium Exchange Mass Spectrometry

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2018English

Chondrocytic Ephrin B2 Promotes Cartilage Destruction by Osteoclasts in Endochondral Ossification

Development (Cambridge)
Developmental BiologyMolecular Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy